High costs, limited insurance coverage, and adherence challenges remain key barriers to broader SLIT use in the US, Larenas-Linnemann says in an interview at AAAAI 2026.
Désirée Larenas-Linnemann, MD
Advertisement
Désirée Larenas-Linnemann, MD, from Hospital Médica Sur
Articles by Désirée Larenas-Linnemann, MD
At AAAAI 2026, Larenas-Linnemann discusses evidence, safety, and long-term benefits of sublingual immunotherapy for allergic rhinitis and asthma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Ecnoglutide Delivers 35% Greater Weight Loss Than Semaglutide in Head-to-Head Trial
2
Sutezolid Shows Promise as Safer Oxazolidinone in Novel 4-Month TB Regimen
3
Tezepelumab Reduces Severe Asthma Exacerbations by 70% in Phase 4 PASSAGE
4
twiist AID System Improves HbA1c, Time in Range in Insulin-Treated Type 2 Diabetes
5